 |
 Play Video: The Importance of Insider Buying
|
|
|
| Date | Insider | Price | Amount |
|---|
3-26-2024
Insider Buy |
Casdin Capital, LLC
Director |
$5.10
CAGR »
|
$203,992.00
40,000 shares |
3-25-2024
Insider Buy |
Casdin Capital, LLC
Director |
$5.02
CAGR »
|
$3,899,050.16
777,377 shares |
8-10-2023
Insider Buy |
Global Healthcare Master Fund, LP Kynam
>10% Owner |
$5.92
CAGR »
|
$3,564,314.88
601,828 shares |
8-10-2023
Insider Buy |
Capital Management, LP Kynam
>10% Owner |
$5.92
CAGR »
|
$3,564,314.88
601,828 shares |
3-17-2022
Insider Buy |
Nick Leschly
President and CEO |
$12.20
CAGR »
|
$4,500,055.40
368,857 shares |
Also See: Institutional Holders of TSVT
Also See: SEC filings
Below we present the annualized performance delivered by TSVT stock since 3-26-2024 (the date of the most recent
insider purchase). The performance of the investment from the time TSVT insider buying occurred is the ultimate
test of whether insiders were right about TSVT being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
03/27/2024 |
|
| End date: |
01/17/2025 |
|
| Start price/share: |
$5.38 |
|
| End price/share: |
$2.61 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-51.49% |
|
| Annualized Gain: |
-63.49% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$4,851.00 |
|
| Years: |
0.81 |
|
TSVT Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent TSVT insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding TSVT
|
|
Free TSVT Email Alerts:
